Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gabriella Berlanda"'
Autor:
Fiorenza De Rose, Salvatore Mussari, Lucia Di Brina, Daniele Ravanelli, Francesco Ziglio, Loris Menegotti, Antonella Ferro, Alessia Caldara, Gabriella Berlanda, Fabio Gasperetti, Elena Magri, Laura Bandera, Patrizia Ferrazza, Sergio Fersino, Maria Andolina, Andrea Martignano, Anna Delana, Said Bou Selman, Valentina Vanoni
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Salvatore Mussari, Elisabetta Grego, Marvi Valentini, Vincenzo Sabatino, Paola Bondioli, Fabio Gasperetti, Marco Pellegrini, Orazio Caffo, P. Cristofolini, Carmine Fantò, Carlo Messina, Alessia Caldara, Mattia Barbareschi, R. Triolo, Gabriella Berlanda, Giuseppe Carbone, Silvia Lazzeri, Roberta Biondi, Nicola Mirabassi, Antonella Ferro
Publikováno v:
Cancer Research. 80:P2-16
Background: The outcomes of IBC pts who received NC could be different by Subtypes Methods: From 2000 to 2018 we treated 400 II-III stage IBC patients (pts) with NC. We recorded baseline characteristics, type of NC, type of surgery, pCR (defined as t
Autor:
Alessia Caldara, Antonella Ferro, Mariachiara Dipasquale, R. Triolo, Paolina Tuttobene, Marco Pellegrini, Orazio Caffo, Fabio Gasperetti, Daniela Bernardi, Gabriella Berlanda, Mattia Barbareschi, Chiara Trentin, Daniela Cazzolli, Enzo Galligioni, Francesca Maines
Publikováno v:
Cancer Research. 75:P5-21
BACKGROUND: IBC is a heterogeneous disease with several subtypes molecularly identified by gene expression profile. Since subtypes defined by immuhistochemistry (IHC) panel are similar although not identical to molecular subtypes, IHC may represent a
Autor:
Marco Pellegrini, Mattia Barbareschi, Chiara Cantaloni, Silvia Giuliani, Paolo Verderio, Nicola Decarli, Chiara Maura Ciniselli, Daniela Cazzolli, Enzo Polla, Gabriella Berlanda, Daniela Bernardi, R. Triolo, Claudio Luchini, Antonella Ferro, Fabio Gasperetti, Elena Leonardi
Publikováno v:
Virchows Archiv : an international journal of pathology. 469(1)
Human epithelial growth factor receptor 2 (HER2) overexpression and/or amplification is of predictive and prognostic value in infiltrating breast carcinoma (IBC). We evaluated the proportion of HER2-positive cases (score 3 overexpression/score 2 plus
Autor:
Claudio Eccher, Antonella Ferro, Eugenia Tonini R, Daniela Cazzolli, Elena Leonardi, Silvia Fasanella, Chiara Cantaloni, D. Aldovini, Luca Morelli, Mattia Barbareschi, Paolo Palma, Emma Bragantini, Gabriella Berlanda
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 19(4)
Goal of this study was to asses the performance of Aperio computer-assisted analysis for HER2 immunohistochemical measurement in 292 equivocally (score2+) HercepTest immunoreactive breast cancer cases, evaluated by an experienced pathologist and anal
Autor:
Antonella Ferro, Marco Pellegrini, Lucianna Russo, Claudio Eccher, Mattia Barbareschi, Alessia Caldara, Lucia Veronica Cuorvo, Gabriella Berlanda, Fabio Gasperetti, S. Moroso, NL De Carli, R. Triolo, M. C. di Pasquale, Enzo Galligioni
Publikováno v:
Cancer Research. 72:P5-01
Purpose: The aim of our study was to investigate different clinico-biological behavior associated to ILC compared to IDC evaluating implications on survival outcomes Methods: We analyzed data from 3749 cases of IBC treated from 1995 to 2008 and categ
Clinico-pathological features and pathological Complete Responses (pCR) to primary chemotherapy (PC)
Autor:
Mattia Barbareschi, R. Triolo, Marco Pellegrini, Gabriella Berlanda, Antonella Ferro, Alessia Caldara, F. Gasperetti, Enzo Galligioni, Orazio Caffo, Salvatore Mussari
Publikováno v:
European Journal of Cancer Supplements. 6:126
Autor:
Claudio Eccher, Mattia Barbareschi, Silvia Fasanella, Luca Morelli, D. Aldovini, F. Gasperetti, Gabriella Berlanda, E. Leonardi, Emma Bragantini, I Bazzanella, Lucia Veronica Cuorvo, P. Dalla Palma, Antonella Ferro, Chiara Cantaloni
Publikováno v:
Diagnostic Pathology
Diagnostic Pathology, Vol 6, Iss Suppl 1, p S7 (2011)
Diagnostic Pathology, Vol 6, Iss Suppl 1, p S7 (2011)
Background Ki67 labeling index (Ki67 LI), the percentage Ki67 immunoreactive cells, is a measure of tumor proliferation, with important clinical relevance in breast cancer, and it is extremely important to standardize its evaluation. Aim To test the